Germany · 
Who invested in Immatics?
Immatics's investors include Wellington Partners, Amgen, AT Impf GmbH and dievini Hopp Biotech.
Germany · Series E startup
Who invested in Immatics
Funding summaryUpdated 26 Oct 2026
$58Mraised across 1 round since 2017, from 1 source
- Latest round
- Series E, $58MOct 2017
- Investors
- 4
The rounds
- Oct 2017Series E$58M
Wellington Partners- Amgen
- AT Impf GmbH
- dievini Hopp Biotech
Also list them on their own siteParatus Investment
Reported by FinSMEs
Founders and team
From Immatics's own website: 13 on the team.
- Anja UrbanVice President Clinical Operations EU
- Dawn BuchananVice President Clinical Operations
- Ernest LeekVice President Commercial Analytics and Operations
- Jeffrey GraybillVice President CMC Commercial Strategy
- Jennifer ChangVice President Launch Excellence Strategy and Operations
- Jens FritscheVice President Data Intelligence
- Jürgen RichertVice President Information Technology
- Lauren SchroederVice President Marketing
- Liane PreussnerSenior Vice President Clinical Development
- Patricia HessVice President Talent Management
- Amie KrauseChief People Officer
- Jordan SilversteinHead of Strategy
- Jim PepinGeneral Counsel & Corporate Secretary
Everyone who backed them
AmgenCorporate VC1round
AT Impf GmbHno record of our own yet1round
dievini Hopp Biotechno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 5 firms list Immatics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Immatics
How much has Immatics raised?
Immatics has raised $58M across 1 round since 2017.
When did Immatics last raise?
Immatics's most recent round was a Series E of $58M in Oct 2017.
What was Immatics's biggest round?
Its most recent round, $58M in Oct 2017, is also its largest on record.
Who backed Immatics first?
Immatics's first round on record, in Oct 2017, was backed by Wellington Partners, Amgen and AT Impf GmbH and 1 others.
What stage is Immatics at?
Immatics's latest named round is a Series E, in Oct 2017.
Where is Immatics based?
Immatics is based in Germany.
Companies like Immatics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.